RSS feeds
Get topic alerts directly to your email inbox
Here’s an easy way to receive the latest news related to your topic(s) of choice as soon as the articles are published.
1. Copy a url for a topic from the list below.
2. In Outlook, right-click the RSS feeds folder and choose Add a New RSS Feed.
3. Paste the url.
4. Choose Add > OK.
5. Suggestion: Create a subfolder for your topic and an associated rule so they alerts are moved directly into your folder of choice.
Alternately, you may use the same links in any RSS reader application such as Feedly or Innoreader.
Topics
| Aesthetics http://www.bioworld.com/rss/topic/237-aesthetics |
| Aging http://www.bioworld.com/rss/topic/566-aging |
| Analysis and data insight http://www.bioworld.com/rss/topic/109-analysis-and-data-insight |
| Anesthesiology http://www.bioworld.com/rss/topic/238-anesthesiology |
| Artificial intelligence http://www.bioworld.com/rss/5 |
| Asia-Pacific — Includes Asia-Pacific, Australia, China, Japan
http://www.bioworld.com/rss/23 |
| Australia — Includes Australia, TGA http://www.bioworld.com/rss/26 |
| Biomarkers http://www.bioworld.com/rss/topic/543-biomarkers |
| Briefs — Includes appointments and advancements, briefs, deals and M&A, earnings, in the clinic, other news to note, post market, preclinical, products regulatory, products clinical, regulatory actions, regulatory front, stock http://www.bioworld.com/rss/11 |
| Canada — Includes Canada, Health Canada
http://www.bioworld.com/rss/27 |
| Cancer — Includes cancer, oncology http://www.bioworld.com/rss/15 |
| CAR T — Includes CAR T (Cell therapy), CAR T (Gene therapy), CAR T (Immunotherapy) http://www.bioworld.com/rss/8 |
| Cardiovascular http://www.bioworld.com/rss/topic/240-cardiovascular |
| Cell therapy http://www.bioworld.com/rss/6 |
| China — Includes China, NMPA http://www.bioworld.com/rss/28 |
| Clinical — Clinical, in the clinic, products clinical http://www.bioworld.com/rss/12 |
| Coronavirus http://www.bioworld.com/rss/topic/517-coronavirus |
| Deals and M&A — Includes acquisition, asset purchase, collaboration, co-promotion, deals and M&A, deals and M&A (briefs), development, distribution, equity option, government supply contract, grant, joint venture, license, merger, non-profit, research, research only, reverse merger, royalty buyout, service agreement, settlement, spinout, supply only http://www.bioworld.com/rss/14 |
| Dental http://www.bioworld.com/rss/topic/241-dental |
| Dermatologic http://www.bioworld.com/rss/topic/242-dermatologic |
| Diagnostics — Includes artificial intelligence (Diagnostics), biopsy, diagnostics, electrocardiogram, genomics, imaging, liquid biopsy, monitoring, point-of-care http://www.bioworld.com/rss/21 |
| Digital health — Includes algorithm, artificial intelligence, cloud-based platform, cybersecurity, database, digital health, electronic health record, mobile/smartphone app, SAAS, SAMD, software, telehealth http://www.bioworld.com/rss/22 |
| Drug design, drug delivery and technologies http://www.bioworld.com/rss/topic/544-drug-design-drug-delivery-and-technologies |
| Drug resistance http://www.bioworld.com/rss/topic/117-drug-resistance |
| Drugs — Includes antibiotic, antibody, antibody-drug conjugate, antigen, antisense, biosimilar, bispecific antibody, CAR T, cell therapy, drugs, enzyme, gene therapy, generic, immuno-oncology, microbiome, monoclonal antibody, nanotech, natural, oncolytic, peptide, plasma, protein, RNAi, small molecule, vaccine http://www.bioworld.com/rss/18 |
| Ear, nose and throat http://www.bioworld.com/rss/topic/245-ear-nose-and-throat |
| EMA http://www.bioworld.com/rss/topic/430-ema |
| Endocrine/metabolic — Includes diabetes, endocrine/metabolic, obesity http://www.bioworld.com/rss/16 |
| Europe — Includes EMA, Europe, MHRA http://www.bioworld.com/rss/29 |
| FDA http://www.bioworld.com/rss/topic/433-fda |
| Financings — Includes American depositary shares, at-the-market offering, bought deal offering, credit facility, investment, financings, follow-on, IPO, grant, loan, mezzanine, notes offering, PIPE (private investment of public equity), private, private placement, public, registered direct offering, seed, series A, series B, series C, series D, series E, series F, series G, share issue, warrant exercise http://www.bioworld.com/rss/19 |
| Gastrointestinal http://www.bioworld.com/rss/topic/247-gastrointestinal |
| Gene therapy http://www.bioworld.com/rss/7 |
| Genetic/congenital http://www.bioworld.com/rss/topic/548-genetic-congenital |
| Genitourinary/sexual function http://www.bioworld.com/rss/topic/248-genitourinary-sexual-function |
| Gynecology/Obstetrics http://www.bioworld.com/rss/topic/258-gynecology-obstetrics |
| Health Canada http://www.bioworld.com/rss/topic/439-health-canada |
| Hematologic http://www.bioworld.com/rss/topic/249-hematologic |
| HIV/AIDS http://www.bioworld.com/rss/topic/542-hiv-aids |
| Immune http://www.bioworld.com/rss/topic/250-immune |
| Immuno-oncology http://www.bioworld.com/rss/topic/280-immuno-oncology |
| Infection http://www.bioworld.com/rss/topic/251-infection |
| Inflammatory http://www.bioworld.com/rss/topic/252-inflammatory |
| Japan http://www.bioworld.com/rss/30 |
| Latin America http://www.bioworld.com/rss/topic/397-latin-america |
| Medical devices and technologies — Includes sub-topics ranging from artificial intelligence to robotic surgery http://www.bioworld.com/rss/20 |
| Ministry of Health, Labour and Welfare http://www.bioworld.com/rss/topic/460-mhlw |
| Medicines and Healthcare products Regulatory Agency http://www.bioworld.com/rss/topic/458-mhra |
| Microbiome http://www.bioworld.com/rss/9 |
| Middle East North Africa http://www.bioworld.com/rss/topic/398-middle-east-north-africa |
| Musculoskeletal http://www.bioworld.com/rss/topic/253-musculoskeletal |
| Neonatal/pediatrics http://www.bioworld.com/rss/topic/254-neonatal-pediatrics |
| Nephrology http://www.bioworld.com/rss/topic/255-nephrology |
| Neurology/psychiatric http://www.bioworld.com/rss/topic/256-neurology-psychiatric |
| New compound http://www.bioworld.com/rss/topic/546-new-compound |
| Newco news — Feature articles on newly emerging companies http://www.bioworld.com/rss/topic/391-newco-news |
| National Medical Products Administration http://www.bioworld.com/rss/topic/556-nmpa |
| Ocular — Includes ocular, ophthalmic http://www.bioworld.com/rss/17 |
| Omics — Includes genomics, GWAS, metabolomics, omics, proteomics http://www.bioworld.com/rss/10 |
| Orthopedics (medtech) http://www.bioworld.com/rss/topic/262-orthopedics |
| Policy http://www.bioworld.com/rss/topic/575-policy |
| Regulatory — Includes coverage of top regulatory news from global regulatory agencies http://www.bioworld.com/rss/24 |
| Respiratory http://www.bioworld.com/rss/topic/263-respiratory |
| Substance use and poisoning http://www.bioworld.com/rss/topic/545-substance-use-and-poisoning |
| Therapeutic Goods Administration http://www.bioworld.com/rss/topic/488-tga |
| Toxicity/intoxication http://www.bioworld.com/rss/topic/264-toxicity-intoxication |
| U.S. — Includes 510(k), CDRH, Central Drugs Standard Control Organization, CMS, FDA, FTC, NIH, orange book, PDUFA, SEC, U.S. http://www.bioworld.com/rss/31 |
| Urology http://www.bioworld.com/rss/topic/265-urology |
| Women's health— Includes gynecology/obstetrics, women's health http://www.bioworld.com/rss/32 |